Latest Episodes
3
Overview of efficacy and safety data of combination therapy with PARPi and NHAs
Overview of efficacy and safety data of combination therapy with PARPi and NHAs, incorporating the latest data presented and the impact for the treatment...
1
Advanced HCC and not eligible for IO – what are the treatment options?
COR2ED Medical Education: Prof. Dr James Harding, Medical Oncologist at Memorial Sloan Kettering Cancer Center and Prof. Dr Sammy Saab, Gastroenterologist and Transplant Hepatologist...
2
PARPi and NHA combination therapy for patients with mCRPC – a US and EU perspective
COR2ED Medical Education: Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and...
1
Clinical implementation of PARPi monotherapy for prostate cancer patients – a US and EU perspective
COR2ED Medical Education: Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and...
2
The nurses’ perspective: Systemic therapy in endometrial carcinoma
Medical education: Join Lead Nurse Andreia Fernandes and Clinical Nurse Specialist Jo Pearson as they explain how to help patients navigate the side effects...
1
The physicians’ perspective: Systemic therapy in endometrial carcinoma
Medical education: Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment...